New drug aims to reshape bodies in obesity trial
NCT ID NCT07169942
Summary
This study is testing whether an investigational drug called aleniglipron can change body composition—specifically reducing fat mass while preserving muscle—in adults living with obesity. About 71 participants will receive either the drug or a placebo for 40 weeks. The main goal is to see how much total body fat changes, measured by a special X-ray scan.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY, OVERWEIGHT, OR CHRONIC WEIGHT MANAGEMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Phoenix, Arizona, 85020, United States
-
Research Site
Chicago, Illinois, 60602, United States
-
Research Site
Richfield, Minnesota, 55423, United States
-
Research Site
City of Saint Peters, Missouri, 63303, United States
-
Research Site
Rochester, New York, 14609, United States
-
Research Site
Wilmington, North Carolina, 28401, United States
-
Research Site
Norman, Oklahoma, 73069, United States
-
Research Site
Moncks Corner, South Carolina, 29461, United States
-
Research Site
North Charleston, South Carolina, 29405, United States
-
Research Site
Austin, Texas, 78704, United States
-
Research Site
San Antonio, Texas, 78240, United States
Conditions
Explore the condition pages connected to this study.